Evidence map›Paper›PMID 32060393›Full record

ArticleCommunications biology2020

Heme binding of transmembrane signaling proteins undergoing regulated intramembrane proteolysis.

Thomas Kupke, Johann P Klare, Britta Brügger

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors.Protein science : a publication of the Protein Society · 2021
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Thomas KupkeHeidelberg University Biochemistry Center, Heidelberg, Germany. thomas.kupke@bzh.uni-heidelberg.de.ORCID http://orcid.org/0000-0003-2341-1710
Johann P KlareDepartment of Physics, University of Osnabrück, Osnabrück, Germany.ORCID http://orcid.org/0000-0002-5761-5968
Britta BrüggerHeidelberg University Biochemistry Center, Heidelberg, Germany. britta.bruegger@bzh.uni-heidelberg.de.
Heidelberg University · DEOsnabrück University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transmembrane signaling proteins play a crucial role in the transduction of information across cell membranes. One function of regulated intramembrane proteolysis (RIP) is the release of signaling factors from transmembrane proteins. To study the role of transmembrane domains (TMDs) in modulating structure and activity of released signaling factors, we purified heterologously expressed human transmembrane proteins and their proteolytic processing products from Escherichia coli. Here we show that CD74 and TNFα are heme binding proteins. Heme coordination depends on both a cysteine residue proximal to the membrane and on the oligomerization of the TMD. Furthermore, we show that the various processing products have different modes of heme coordination. We suggest that RIP changes the mode of heme binding of these proteins and generates heme binding peptides with yet unexplored functions. The identification of a RIP modulated cofactor binding of transmembrane signaling proteins sheds new light on the regulation of cell signaling pathways.

Indexed as

ProteolysisAntigens, Differentiation, B-LymphocyteCell MembraneHemeHistocompatibility Antigens Class IIHumansIronMembrane ProteinsProtein BindingProtein Interaction Domains and MotifsProtein IsoformsProtein Processing, Post-TranslationalSignal TransductionTumor Necrosis Factor-alphaAntigens, Differentiation, B-LymphocyteHemeHistocompatibility Antigens Class IIinvariant chainIronMembrane ProteinsProtein IsoformsTumor Necrosis Factor-alpha

Identifiers

PMID32060393
PMCPMC7021776
OpenAlexW3006074420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.